Company Failed to Check Out Patient’s Drug Complaint, FDA Says Post author:Sam Post published:October 20, 2017 Post category:Drug Industry Daily A Texas drugmaker was flagged by the FDA for failing to follow up on a patient’s complaint. Source: Drug Industry Daily You Might Also Like House Subcommittee Quizzes Califf on New Role for Woodcock, Status of Foreign Inspections in Budget Hearing May 19, 2022 FDA Oncology Leaders Sketch Out New Trial Designs for Accelerated Approvals September 26, 2022 Sanders, Cummings Request Info on FDA’s Emflaza Approval March 16, 2017
House Subcommittee Quizzes Califf on New Role for Woodcock, Status of Foreign Inspections in Budget Hearing May 19, 2022